1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 TIL 1.2.3 LAK 1.2.4 CAR-T 1.2.5 TCR-T 1.2.6 CIK 1.2.7 NK 1.2.8 DC 1.2.9 Other 1.3 Market by Application 1.3.1 Global Adoptive Cellular Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Cancer Hospital 1.3.4 Centers for Disease Control and Prevention 1.3.5 Rehabilitation Center 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Adoptive Cellular Immunotherapy Market Perspective (2016-2027) 2.2 Adoptive Cellular Immunotherapy Growth Trends by Regions 2.2.1 Adoptive Cellular Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Adoptive Cellular Immunotherapy Historic Market Share by Regions (2016-2021) 2.2.3 Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2022-2027) 2.3 Adoptive Cellular Immunotherapy Industry Dynamic 2.3.1 Adoptive Cellular Immunotherapy Market Trends 2.3.2 Adoptive Cellular Immunotherapy Market Drivers 2.3.3 Adoptive Cellular Immunotherapy Market Challenges 2.3.4 Adoptive Cellular Immunotherapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue 3.1.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue (2016-2021) 3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2016-2021) 3.2 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue 3.4 Global Adoptive Cellular Immunotherapy Market Concentration Ratio 3.4.1 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cellular Immunotherapy Revenue in 2020 3.5 Adoptive Cellular Immunotherapy Key Players Head office and Area Served 3.6 Key Players Adoptive Cellular Immunotherapy Product Solution and Service 3.7 Date of Enter into Adoptive Cellular Immunotherapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Adoptive Cellular Immunotherapy Breakdown Data by Type 4.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Type (2016-2021) 4.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2022-2027) 5 Adoptive Cellular Immunotherapy Breakdown Data by Application 5.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Application (2016-2021) 5.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Adoptive Cellular Immunotherapy Market Size (2016-2027) 6.2 North America Adoptive Cellular Immunotherapy Market Size by Type 6.2.1 North America Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) 6.2.2 North America Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) 6.2.3 North America Adoptive Cellular Immunotherapy Market Size by Type (2016-2027) 6.3 North America Adoptive Cellular Immunotherapy Market Size by Application 6.3.1 North America Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) 6.3.2 North America Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) 6.3.3 North America Adoptive Cellular Immunotherapy Market Size by Application (2016-2027) 6.4 North America Adoptive Cellular Immunotherapy Market Size by Country 6.4.1 North America Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) 6.4.2 North America Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Adoptive Cellular Immunotherapy Market Size (2016-2027) 7.2 Europe Adoptive Cellular Immunotherapy Market Size by Type 7.2.1 Europe Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) 7.2.2 Europe Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) 7.2.3 Europe Adoptive Cellular Immunotherapy Market Size by Type (2016-2027) 7.3 Europe Adoptive Cellular Immunotherapy Market Size by Application 7.3.1 Europe Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) 7.3.2 Europe Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) 7.3.3 Europe Adoptive Cellular Immunotherapy Market Size by Application (2016-2027) 7.4 Europe Adoptive Cellular Immunotherapy Market Size by Country 7.4.1 Europe Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) 7.4.2 Europe Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size (2016-2027) 8.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type 8.2.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application 8.3.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region 8.4.1 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Adoptive Cellular Immunotherapy Market Size (2016-2027) 9.2 Latin America Adoptive Cellular Immunotherapy Market Size by Type 9.2.1 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) 9.2.2 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) 9.2.3 Latin America Adoptive Cellular Immunotherapy Market Size by Type (2016-2027) 9.3 Latin America Adoptive Cellular Immunotherapy Market Size by Application 9.3.1 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) 9.3.2 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) 9.3.3 Latin America Adoptive Cellular Immunotherapy Market Size by Application (2016-2027) 9.4 Latin America Adoptive Cellular Immunotherapy Market Size by Country 9.4.1 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) 9.4.2 Latin America Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size (2016-2027) 10.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type 10.2.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application 10.3.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country 10.4.1 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen Inc 11.1.1 Amgen Inc Company Details 11.1.2 Amgen Inc Business Overview 11.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction 11.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.1.5 Amgen Inc Recent Development 11.2 Autolus Therapeutics Plc 11.2.1 Autolus Therapeutics Plc Company Details 11.2.2 Autolus Therapeutics Plc Business Overview 11.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction 11.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.2.5 Autolus Therapeutics Plc Recent Development 11.3 Beijing Immunochina Medical Science & Technology Co Ltd 11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details 11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview 11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction 11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development 11.4 Bellicum Pharmaceuticals Inc 11.4.1 Bellicum Pharmaceuticals Inc Company Details 11.4.2 Bellicum Pharmaceuticals Inc Business Overview 11.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction 11.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.4.5 Bellicum Pharmaceuticals Inc Recent Development 11.5 Bristol-Myers Squibb Co 11.5.1 Bristol-Myers Squibb Co Company Details 11.5.2 Bristol-Myers Squibb Co Business Overview 11.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction 11.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.5.5 Bristol-Myers Squibb Co Recent Development 11.6 bluebird bio Inc 11.6.1 bluebird bio Inc Company Details 11.6.2 bluebird bio Inc Business Overview 11.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction 11.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.6.5 bluebird bio Inc Recent Development 11.7 CARsgen Therapeutics Ltd 11.7.1 CARsgen Therapeutics Ltd Company Details 11.7.2 CARsgen Therapeutics Ltd Business Overview 11.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction 11.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.7.5 CARsgen Therapeutics Ltd Recent Development 11.8 Celgene Corp 11.8.1 Celgene Corp Company Details 11.8.2 Celgene Corp Business Overview 11.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction 11.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.8.5 Celgene Corp Recent Development 11.9 Cell Medica Ltd 11.9.1 Cell Medica Ltd Company Details 11.9.2 Cell Medica Ltd Business Overview 11.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction 11.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.9.5 Cell Medica Ltd Recent Development 11.10 Cellular Biomedicine Group Inc 11.10.1 Cellular Biomedicine Group Inc Company Details 11.10.2 Cellular Biomedicine Group Inc Business Overview 11.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction 11.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.10.5 Cellular Biomedicine Group Inc Recent Development 11.11 Celularity Inc 11.11.1 Celularity Inc Company Details 11.11.2 Celularity Inc Business Overview 11.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction 11.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.11.5 Celularity Inc Recent Development 11.12 Celyad SA 11.12.1 Celyad SA Company Details 11.12.2 Celyad SA Business Overview 11.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction 11.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.12.5 Celyad SA Recent Development 11.13 Daiichi Sankyo Co Ltd 11.13.1 Daiichi Sankyo Co Ltd Company Details 11.13.2 Daiichi Sankyo Co Ltd Business Overview 11.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction 11.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.13.5 Daiichi Sankyo Co Ltd Recent Development 11.14 Fosun Pharmaceutical AG 11.14.1 Fosun Pharmaceutical AG Company Details 11.14.2 Fosun Pharmaceutical AG Business Overview 11.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction 11.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.14.5 Fosun Pharmaceutical AG Recent Development 11.15 Gilead Sciences Inc 11.15.1 Gilead Sciences Inc Company Details 11.15.2 Gilead Sciences Inc Business Overview 11.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction 11.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.15.5 Gilead Sciences Inc Recent Development 11.16 Guangzhou Anjie Biomedical Technology Co Ltd 11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details 11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview 11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction 11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development 11.17 Hangzhou Converd Co Ltd 11.17.1 Hangzhou Converd Co Ltd Company Details 11.17.2 Hangzhou Converd Co Ltd Business Overview 11.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction 11.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.17.5 Hangzhou Converd Co Ltd Recent Development 11.18 Hebei Senlang Biotechnology Inc Ltd 11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details 11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview 11.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction 11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development 11.18 HRAIN Biotechnology Co Ltd 11.25.1 HRAIN Biotechnology Co Ltd Company Details 11.25.2 HRAIN Biotechnology Co Ltd Business Overview 11.25.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction 11.25.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.25.5 HRAIN Biotechnology Co Ltd Recent Development 11.20 Juno Therapeutics Inc 11.20.1 Juno Therapeutics Inc Company Details 11.20.2 Juno Therapeutics Inc Business Overview 11.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction 11.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.20.5 Juno Therapeutics Inc Recent Development 11.21 Kite Pharma Inc 11.21.1 Kite Pharma Inc Company Details 11.21.2 Kite Pharma Inc Business Overview 11.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction 11.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.21.5 Kite Pharma Inc Recent Development 11.22 Nanjing Legend Biotech Co Ltd 11.22.1 Nanjing Legend Biotech Co Ltd Company Details 11.22.2 Nanjing Legend Biotech Co Ltd Business Overview 11.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction 11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.22.5 Nanjing Legend Biotech Co Ltd Recent Development 11.23 NantKwest Inc 11.23.1 NantKwest Inc Company Details 11.23.2 NantKwest Inc Business Overview 11.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction 11.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.23.5 NantKwest Inc Recent Development 11.24 Nkarta Inc 11.24.1 Nkarta Inc Company Details 11.24.2 Nkarta Inc Business Overview 11.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction 11.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.24.5 Nkarta Inc Recent Development 11.25 Novartis AG 11.25.1 Novartis AG Company Details 11.25.2 Novartis AG Business Overview 11.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction 11.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.25.5 Novartis AG Recent Development 11.26 Ono Pharmaceutical Co Ltd 11.26.1 Ono Pharmaceutical Co Ltd Company Details 11.26.2 Ono Pharmaceutical Co Ltd Business Overview 11.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction 11.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.26.5 Ono Pharmaceutical Co Ltd Recent Development 11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd 11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details 11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview 11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction 11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development 11.28 Sorrento Therapeutics Inc 11.28.1 Sorrento Therapeutics Inc Company Details 11.28.2 Sorrento Therapeutics Inc Business Overview 11.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction 11.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.28.5 Sorrento Therapeutics Inc Recent Development 11.29 Takara Bio Inc 11.29.1 Takara Bio Inc Company Details 11.29.2 Takara Bio Inc Business Overview 11.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction 11.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) 11.29.5 Takara Bio Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of TIL Table 3. Key Players of LAK Table 4. Key Players of CAR-T Table 5. Key Players of TCR-T Table 6. Key Players of CIK Table 7. Key Players of NK Table 8. Key Players of DC Table 9. Key Players of Other Table 10. Global Adoptive Cellular Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Adoptive Cellular Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Adoptive Cellular Immunotherapy Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Adoptive Cellular Immunotherapy Market Share by Regions (2016-2021) Table 14. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Adoptive Cellular Immunotherapy Market Share by Regions (2022-2027) Table 16. Adoptive Cellular Immunotherapy Market Trends Table 17. Adoptive Cellular Immunotherapy Market Drivers Table 18. Adoptive Cellular Immunotherapy Market Challenges Table 19. Adoptive Cellular Immunotherapy Market Restraints Table 20. Global Adoptive Cellular Immunotherapy Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Adoptive Cellular Immunotherapy Market Share by Players (2016-2021) Table 22. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cellular Immunotherapy as of 2020) Table 23. Ranking of Global Top Adoptive Cellular Immunotherapy Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Adoptive Cellular Immunotherapy Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Adoptive Cellular Immunotherapy Product Solution and Service Table 27. Date of Enter into Adoptive Cellular Immunotherapy Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) (US$ Million) Table 30. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2016-2021) Table 31. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Adoptive Cellular Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Adoptive Cellular Immunotherapy Revenue Market Share by Application (2016-2021) Table 35. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Adoptive Cellular Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) (US$ Million) Table 38. North America Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) (US$ Million) Table 40. North America Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Adoptive Cellular Immunotherapy Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Adoptive Cellular Immunotherapy Market Size by Country (2022-2027) & (US$ Million) Table 67. Amgen Inc Company Details Table 68. Amgen Inc Business Overview Table 69. Amgen Inc Adoptive Cellular Immunotherapy Product Table 70. Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 71. Amgen Inc Recent Development Table 72. Autolus Therapeutics Plc Company Details Table 73. Autolus Therapeutics Plc Business Overview Table 74. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Table 75. Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 76. Autolus Therapeutics Plc Recent Development Table 77. Beijing Immunochina Medical Science & Technology Co Ltd Company Details Table 78. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview Table 79. Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product Table 80. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 81. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development Table 82. Bellicum Pharmaceuticals Inc Company Details Table 83. Bellicum Pharmaceuticals Inc Business Overview Table 84. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Table 85. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 86. Bellicum Pharmaceuticals Inc Recent Development Table 87. Bristol-Myers Squibb Co Company Details Table 88. Bristol-Myers Squibb Co Business Overview Table 89. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Table 90. Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 91. Bristol-Myers Squibb Co Recent Development Table 92. bluebird bio Inc Company Details Table 93. bluebird bio Inc Business Overview Table 94. bluebird bio Inc Adoptive Cellular Immunotherapy Product Table 95. bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 96. bluebird bio Inc Recent Development Table 97. CARsgen Therapeutics Ltd Company Details Table 98. CARsgen Therapeutics Ltd Business Overview Table 99. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Table 100. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 101. CARsgen Therapeutics Ltd Recent Development Table 102. Celgene Corp Company Details Table 103. Celgene Corp Business Overview Table 104. Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 105. Celgene Corp Recent Development Table 106. Cell Medica Ltd Company Details Table 107. Cell Medica Ltd Business Overview Table 108. Cell Medica Ltd Adoptive Cellular Immunotherapy Product Table 109. Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 110. Cell Medica Ltd Recent Development Table 111. Cellular Biomedicine Group Inc Company Details Table 112. Cellular Biomedicine Group Inc Business Overview Table 113. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Table 114. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 115. Cellular Biomedicine Group Inc Recent Development Table 116. Celularity Inc Company Details Table 117. Celularity Inc Business Overview Table 118. Celularity Inc Adoptive Cellular Immunotherapy Product Table 119. Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 120. Celularity Inc Recent Development Table 121. Celyad SA Company Details Table 122. Celyad SA Business Overview Table 123. Celyad SA Adoptive Cellular Immunotherapy Product Table 124. Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 125. Celyad SA Recent Development Table 126. Daiichi Sankyo Co Ltd Company Details Table 127. Daiichi Sankyo Co Ltd Business Overview Table 128. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Table 129. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 130. Daiichi Sankyo Co Ltd Recent Development Table 131. Fosun Pharmaceutical AG Company Details Table 132. Fosun Pharmaceutical AG Business Overview Table 133. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Table 134. Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 135. Fosun Pharmaceutical AG Recent Development Table 136. Gilead Sciences Inc Company Details Table 137. Gilead Sciences Inc Business Overview Table 138. Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Table 139. Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 140. Gilead Sciences Inc Recent Development Table 141. Guangzhou Anjie Biomedical Technology Co Ltd Company Details Table 142. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview Table 143. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Table 144. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 145. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development Table 146. Hangzhou Converd Co Ltd Company Details Table 147. Hangzhou Converd Co Ltd Business Overview Table 148. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Table 149. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 150. Hangzhou Converd Co Ltd Recent Development Table 151. Hebei Senlang Biotechnology Inc Ltd Company Details Table 152. Hebei Senlang Biotechnology Inc Ltd Business Overview Table 153. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Table 154. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 155. Hebei Senlang Biotechnology Inc Ltd Recent Development Table 156. HRAIN Biotechnology Co Ltd Company Details Table 157. HRAIN Biotechnology Co Ltd Business Overview Table 158. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Table 159. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 160. HRAIN Biotechnology Co Ltd Recent Development Table 161. Juno Therapeutics Inc Company Details Table 162. Juno Therapeutics Inc Business Overview Table 163. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Table 164. Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 165. Juno Therapeutics Inc Recent Development Table 166. Kite Pharma Inc Company Details Table 167. Kite Pharma Inc Business Overview Table 168. Kite Pharma Inc Adoptive Cellular Immunotherapy Product Table 169. Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 170. Kite Pharma Inc Recent Development Table 171. Nanjing Legend Biotech Co Ltd Company Details Table 172. Nanjing Legend Biotech Co Ltd Business Overview Table 173. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Table 174. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 175. Nanjing Legend Biotech Co Ltd Recent Development Table 176. NantKwest Inc Company Details Table 177. NantKwest Inc Business Overview Table 178. NantKwest Inc Adoptive Cellular Immunotherapy Product Table 179. NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 180. NantKwest Inc Recent Development Table 181. Nkarta Inc Company Details Table 182. Nkarta Inc Business Overview Table 183. Nkarta Inc Adoptive Cellular ImmunotherapyProduct Table 184. Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 185. Nkarta Inc Recent Development Table 186. Novartis AG Company Details Table 187. Novartis AG Business Overview Table 188. Novartis AG Adoptive Cellular Immunotherapy Product Table 189. Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 190. Novartis AG Recent Development Table 191. Ono Pharmaceutical Co Ltd Company Details Table 192. Ono Pharmaceutical Co Ltd Business Overview Table 193. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Table 194. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 195. Ono Pharmaceutical Co Ltd Recent Development Table 196. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details Table 197. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview Table 198. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Table 199. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 200. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development Table 201. Sorrento Therapeutics Inc Company Details Table 202. Sorrento Therapeutics Inc Business Overview Table 203. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Table 204. Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 205. Sorrento Therapeutics Inc Recent Development Table 206. Takara Bio Inc Company Details Table 207. Takara Bio Inc Business Overview Table 208. Takara Bio Inc Adoptive Cellular Immunotherapy Product Table 209. Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2016-2021) & (US$ Million) Table 210. Takara Bio Inc Recent Development Table 211. Research Programs/Design for This Report Table 212. Key Data Information from Secondary Sources Table 213. Key Data Information from Primary Sources List of Figures Figure 1. Global Adoptive Cellular Immunotherapy Market Share by Type: 2020 VS 2027 Figure 2. TIL Features Figure 3. LAK Features Figure 4. CAR-T Features Figure 5. TCR-T Features Figure 6. CIK Features Figure 7. NK Features Figure 8. DC Features Figure 9. Other Features Figure 10. Global Adoptive Cellular Immunotherapy Market Share by Application: 2020 VS 2027 Figure 11. Hospital Case Studies Figure 12. Cancer Hospital Case Studies Figure 13. Centers for Disease Control and Prevention Case Studies Figure 14. Rehabilitation Center Case Studies Figure 15. Other Case Studies Figure 16. Adoptive Cellular Immunotherapy Report Years Considered Figure 17. Global Adoptive Cellular Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 18. Global Adoptive Cellular Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 19. Global Adoptive Cellular Immunotherapy Market Share by Regions: 2020 VS 2027 Figure 20. Global Adoptive Cellular Immunotherapy Market Share by Regions (2022-2027) Figure 21. Global Adoptive Cellular Immunotherapy Market Share by Players in 2020 Figure 22. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cellular Immunotherapy as of 2020 Figure 23. The Top 10 and 5 Players Market Share by Adoptive Cellular Immunotherapy Revenue in 2020 Figure 24. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2016-2021) Figure 25. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2022-2027) Figure 26. North America Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. North America Adoptive Cellular Immunotherapy Market Share by Type (2016-2027) Figure 28. North America Adoptive Cellular Immunotherapy Market Share by Application (2016-2027) Figure 29. North America Adoptive Cellular Immunotherapy Market Share by Country (2016-2027) Figure 30. United States Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Canada Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Adoptive Cellular Immunotherapy Market Share by Type (2016-2027) Figure 34. Europe Adoptive Cellular Immunotherapy Market Share by Application (2016-2027) Figure 35. Europe Adoptive Cellular Immunotherapy Market Share by Country (2016-2027) Figure 36. Germany Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. France Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. U.K. Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Italy Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Russia Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Nordic Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Adoptive Cellular Immunotherapy Market Share by Type (2016-2027) Figure 44. Asia-Pacific Adoptive Cellular Immunotherapy Market Share by Application (2016-2027) Figure 45. Asia-Pacific Adoptive Cellular Immunotherapy Market Share by Region (2016-2027) Figure 46. China Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Japan Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. South Korea Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Southeast Asia Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. India Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Australia Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Adoptive Cellular Immunotherapy Market Share by Type (2016-2027) Figure 54. Latin America Adoptive Cellular Immunotherapy Market Share by Application (2016-2027) Figure 55. Latin America Adoptive Cellular Immunotherapy Market Share by Country (2016-2027) Figure 56. Mexico Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Brazil Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Adoptive Cellular Immunotherapy Market Share by Type (2016-2027) Figure 60. Middle East & Africa Adoptive Cellular Immunotherapy Market Share by Application (2016-2027) Figure 61. Middle East & Africa Adoptive Cellular Immunotherapy Market Share by Country (2016-2027) Figure 62. Turkey Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Saudi Arabia Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. UAE Adoptive Cellular Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. Amgen Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 66. Autolus Therapeutics Plc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 67. Beijing Immunochina Medical Science & Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 68. Bellicum Pharmaceuticals Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 69. Bristol-Myers Squibb Co Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 70. bluebird bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 71. CARsgen Therapeutics Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 72. Celgene Corp Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 73. Cell Medica Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 74. Cellular Biomedicine Group Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 75. Celularity Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 76. Celyad SA Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 77. Daiichi Sankyo Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 78. Fosun Pharmaceutical AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 79. Gilead Sciences Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 80. Guangzhou Anjie Biomedical Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 81. Hangzhou Converd Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 82. Hebei Senlang Biotechnology Inc Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 83. HRAIN Biotechnology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 84. Juno Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 85. Kite Pharma Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 86. Nanjing Legend Biotech Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 87. NantKwest Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 88. Nkarta Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 89. Novartis AG Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 90. Ono Pharmaceutical Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 91. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 92. Sorrento Therapeutics Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 93. Takara Bio Inc Revenue Growth Rate in Adoptive Cellular Immunotherapy Business (2016-2021) Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

Amgen Inc Autolus Therapeutics Plc Beijing Immunochina Medical Science & Technology Co Ltd Bellicum Pharmaceuticals Inc Bristol-Myers Squibb Co bluebird bio Inc CARsgen Therapeutics Ltd Celgene Corp Cell Medica Ltd Cellular Biomedicine Group Inc Celularity Inc Celyad SA Daiichi Sankyo Co Ltd Fosun Pharmaceutical AG Gilead Sciences Inc Guangzhou Anjie Biomedical Technology Co Ltd Hangzhou Converd Co Ltd Hebei Senlang Biotechnology Inc Ltd HRAIN Biotechnology Co Ltd Juno Therapeutics Inc Kite Pharma Inc Nanjing Legend Biotech Co Ltd NantKwest Inc Nkarta Inc Novartis AG Ono Pharmaceutical Co Ltd Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Sorrento Therapeutics Inc Takara Bio Inc